BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3371520)

  • 1. Erythema nodosum following thalidomide therapy for Behçet's disease.
    Viraben R; Dupré A
    Dermatologica; 1988; 176(2):107. PubMed ID: 3371520
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of Behçet's disease with thalidomide.
    Hamza MH
    Clin Rheumatol; 1986 Sep; 5(3):365-71. PubMed ID: 3780143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythema nodosum-like lesions in Behçet's disease: a clinicopathological study of 26 cases.
    Misago N; Tada Y; Koarada S; Narisawa Y
    Acta Derm Venereol; 2012 Nov; 92(6):681-6. PubMed ID: 22504656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thalidomide--effect on T cell subsets as a possible mechanism of action.
    Moncada B; Baranda ML; González-Amaro R; Urbina R; Loredo CE
    Int J Lepr Other Mycobact Dis; 1985 Jun; 53(2):201-5. PubMed ID: 3874920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Erythroleukemia in a patient with Behçet's disease under long-term thalidomide therapy].
    Louzir B; Othmani S; Gritli N; Beji M; Zidi B; M'Saddek F; Boussema E; Bahri M
    Ann Med Interne (Paris); 1992; 143(7):479-80. PubMed ID: 1300872
    [No Abstract]   [Full Text] [Related]  

  • 6. Thalidomide: an experience in therapeutic outcome and adverse reactions.
    Sharma NL; Sharma VC; Mahajan VK; Shanker V; Ranjan N; Gupta M
    J Dermatolog Treat; 2007; 18(6):335-40. PubMed ID: 17852637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNF-alpha antagonists and thalidomide for the management of gastrointestinal Behçet's syndrome refractory to the conventional treatment modalities: a case series and review of the literature.
    Hatemi I; Hatemi G; Pamuk ON; Erzin Y; Celik AF
    Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S129-37. PubMed ID: 26486925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thalidomide in the treatment of Behçet's syndrome.
    Saylan T; Saltik I
    Arch Dermatol; 1982 Aug; 118(8):536. PubMed ID: 7103519
    [No Abstract]   [Full Text] [Related]  

  • 9. Refractory Behçet's disease treated with low-dose interleukin-2: A case report.
    Zhou W; Liu T; Xiao X; He J
    Medicine (Baltimore); 2022 Oct; 101(42):e31173. PubMed ID: 36281176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythema nodosum-arthopathy complex as an initial presentation of Behçet's disease. Report of five cases.
    Frayha RA; Nasr FW
    J Rheumatol; 1978; 5(2):224-8. PubMed ID: 671441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exacerbation of psoriasis by thalidomide in Behçet's syndrome.
    Dobson CM; Parslew RA
    Br J Dermatol; 2003 Aug; 149(2):432-3. PubMed ID: 12932265
    [No Abstract]   [Full Text] [Related]  

  • 12. Unilateral erythema nodosum-like lesions and superficial thrombophlebitis together with ipsilateral thrombosis of the vena femoralis in Behçet's disease.
    Akman A; Yilmaz E; Ciftcioglu MA; Alpsoy E
    Eur J Dermatol; 2006; 16(6):703-4. PubMed ID: 17229626
    [No Abstract]   [Full Text] [Related]  

  • 13. Potassium iodide in the treatment of erythema nodosum and nodular vasculitis.
    Horio T; Imamura S; Danno K; Ofuji S
    Arch Dermatol; 1981 Jan; 117(1):29-31. PubMed ID: 7458376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe erythema nodosum due to Behçet's disease responsive to erythromycin.
    Kaya TI; Tursen U; Baz K; Ikizoglu G; Dusmez D
    J Dermatolog Treat; 2003 Jun; 14(2):124-7. PubMed ID: 12775321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind trial of colchicine in Behçet's syndrome.
    Yurdakul S; Mat C; Tüzün Y; Ozyazgan Y; Hamuryudan V; Uysal O; Senocak M; Yazici H
    Arthritis Rheum; 2001 Nov; 44(11):2686-92. PubMed ID: 11710724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Weight gain during treatment with thalidomide: a case report].
    Comte H; Béné J; Auffret M; Gautier S; Salle-Staumont D
    Therapie; 2014; 69(5):457-9. PubMed ID: 25285366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thalidomide: dermatological indications, mechanisms of action and side-effects.
    Wu JJ; Huang DB; Pang KR; Hsu S; Tyring SK
    Br J Dermatol; 2005 Aug; 153(2):254-73. PubMed ID: 16086735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thalidomide in the treatment of neuro-Behçet's syndrome.
    Ranselaar CG; Boone RM; Kluin-Nelemans HC
    Br J Dermatol; 1986 Sep; 115(3):367-70. PubMed ID: 3756093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behcet's disease without oral ulcers presenting with erythema nodosum and deep venous thrombosis.
    Ajmani S; Chowdhury AC; Misra DP; Agarwal V
    Trop Doct; 2016 Jan; 46(1):34-6. PubMed ID: 26220926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrastructure of lymphocyte-mediated fat-cell lysis in erythema nodosum-like lesions of Behçet's syndrome.
    Honma T; Bang D; Saito T; Nakagawa S; Ueki H; Lee S
    Arch Dermatol; 1987 Dec; 123(12):1650-4. PubMed ID: 3688905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.